Sales ended at MNOK 67.9 for the quarter (MNOK 61.6),
a 10.2 % growth. Sales as of September increased by
13.5 % and ended at MOK 200.6 (MNOK 176.8). The
revenue growth is driven by sales of own products and
currency neutral growth was 13.0 % for the quarter and
16.1 % YTD. Operating profit (EBIT) for the quarter
ended at MNOK 15.9 (MNOK 12.7). Operating profit as of
September ended at MNOK 46.6 (MNOK 34.3.) an increase
of 36.0 %.
The 3rd quarter was a new record quarter in the US
with a currency neutral growth of 14.9 %. Also a
strong sales of ultrasound imaging products in Asia
and Australia contributed to the growth in the 3rd
quarter.
Profit per share increased with 8.6 % for the quarter
and ended at NOK 0.62 (NOK 0.57). Accumulated profit
per share was NOK 1.83 (NOK 1.56).